Related Experiment Video

Updated: Jul 7, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

Cell therapy for diabetes mellitus: an opportunity for stem cells?

B Soria1, F J Bedoya, J R Tejedo

  • 1CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine), Isla de la Cartuja, Seville, Spain. bernat.soria@cabimer.es

Cells, Tissues, Organs
|February 29, 2008
PubMed

Insights

Stem cell therapy shows promise for diabetes treatment by generating insulin-producing cells. Further research is needed to create fully functional beta cells for clinical applications in managing diabetes complications.

Area of Science:

  • Endocrinology
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Diabetes mellitus is a chronic condition marked by insufficient beta cell mass and impaired glucose homeostasis.
  • These issues lead to severe complications and reduced life expectancy, making diabetes a prime target for cell therapy.
  • Current treatments like pancreas and islet transplantation face donor organ shortages, driving the search for alternative beta cell sources.

Purpose of the Study:

  • To review recent advancements in generating insulin-producing cells from embryonic and adult stem cells for diabetes treatment.
  • To discuss the challenges and future directions for the clinical application of stem cell-based diabetes therapy.

Main Methods:

  • Utilizing embryonic and adult stem cells to generate insulin-producing cells.
  • Transplanting these generated cells into diabetic animal models to assess efficacy.
  • Evaluating the functional attributes of stem cell-derived insulin-producing cells.

Main Results:

  • Studies have successfully generated insulin-secreting cells from various stem cell sources.
  • Transplantation of these cells into diabetic animal models has shown normalization of blood glucose levels.
  • Stem cell-derived insulin-producing cells currently lack the full complexity and functionality of native beta cells.

Conclusions:

  • Stem cell-derived cells offer a potential alternative to traditional transplantation for diabetes.
  • Further refinement in differentiation and selection methods is crucial for developing fully functional beta cells.
  • Autologous stem cell therapies may offer future benefits for managing late-stage diabetic complications.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...